999
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Fluorescence, circular dichroism, NMR, and docking studies of the interaction of the alkaloid malbrancheamide with calmodulin

, , , , , & show all
Pages 378-385 | Received 23 Apr 2010, Accepted 15 Aug 2010, Published online: 13 Oct 2010
 

Abstract

A new malbrancheamide analogue, isomalbrancheamide B (3), along with three known compounds, malbrancheamide (1), isomalbrancheamide (2), and premalbrancheamide (4), were isolated in higher yields from the alkaloid fraction of the fungus Malbranchea aurantiaca. The interaction of the alkaloids 1–4 with calmodulin (CaM) was analyzed using different enzymatic, fluorescence, spectroscopic, nuclear magnetic resonance (NMR), and molecular modelling techniques. On the basis of the enzymatic and fluorescence experiments, malbrancheamides 1–3 are classical CaM inhibitors. Compound 4, however, did not quench the extrinsic fluorescence of the CaM biosensor indicating that it could be a functional inhibitor. Circular dichroism, NMR, and molecular modelling studies revealed that 1 binds to CaM in the same hydrophobic pocket than the chlorpromazine and trifluoperazine, two classical CaM inhibitors. Thus, malbrancheamide and related monochlorinated analogues are compounds with a high potential for the development of new therapeutic agents, involving CaM as their molecular target.

Acknowledgements

The technical assistance of Georgina Duarte-Lisci, Margarita Guzmán-Villanueva, Marisela Gutiérrez, Isabel Rivero-Cruz and Isabel Velázquez-López is also recognized. The authors are very grateful to Dr. A. Olson and his colleagues at the Scripps Research Institute for providing AutoDock. The authors are indebted to Dirección General de Servicios de Cómputo Académico (DGSCA, UNAM), for providing the resources to carry out computational calculations through KanBalam System.

Declaration of interest

This work was supported by Consejo Nacional de Ciencia y Tecnología (CONACyT, grant 99395).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.